Regional Anaesthesia and Thromboprophylaxis Dr Kate Fogg Royal Brompton Hospital.

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

Implementing NICE guidance
ANTICOAGULANT THERAPY REVISITED 2004 or, Which one(s) of these drugs should be the one(s) I use, and for what?
Dr. Abdullah Ahmad Ghazi (R5) KSMC 8 May  TURP  gold standard in BPH  Using of A-Cog & A-Plt is increasing.  4% on A-Cog  37% on A-plt.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
State Secretary, ISA, TamilNadu
Basic Clinician Training Module 5
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Prophylaxis of Venous Thromboembolism
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
CMS Core Measures Evidence-Based Performance Measurement.
ANAESTHESIA AND ANTICOAGULANTS
NEURAXIAL BLOCKADE AND ANTICOAGULANTS Developing Countries Regional Anesthesia Lecture Series Daniel D. Moos CRNA, Ed.D. U.S.A.
Regional Anesthetics and Anticoagulation Marie Sankaran Raval M.D. Boston Medical Center Department of Anesthesiology Nina Zachariah M.D.
Vascular Pharmacology
Jen Sackrison Anesthesia Clerkship 9/2/11
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
ANTICOAGULANT BY :DR ISRAA OMAR.
Atrial Fibrillation Warfarin and its newer alternatives
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
Venous Thromboembolism
Oral anticoagulants and regional anesthesia for joint replacement surgery Reported by R1 康庭瑞 2002/11/5.
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Clopidogrel 75 mg per day orally should be added to aspirin in patients with STEMI regardless of whether they undergo reperfusion.
VTE Prevention In Action Interactive Case Scenarios.
PRE-OPERATIVE PRE - MEDICATION. Pre-medication  Pre-medication is the administration of drugs before anesthesia.  Pre-medication is used to prepare.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Antithrombotic Trialists’ Collaboration An updated collaborative overview of randomised trials of antiplatelet therapy among high-risk patients.
ANTIPLATELETES AGENTS BY :DR. ISRAA OMAR. The role of platelets Platelets play a critical role in thromboembolic disease like ischemic heart disease and.
ANTIPLATELETES AGENTS
Antiplatelets, Anticoagulants What are the consequences Dr Jeremy Wright Cardiologist Hearts1st, Greenslopes Private Hospital.
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy R. Rossini, G. Musumeci,
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
Agents Affecting Blood Clotting
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Anticoagulated patients and neuraxial anaesthesia Dr.Srinivas Kallam Consultant anaesthetist, University Hospitals Leicester NHS trust.
Can the Epidural Catheter Be Removed with Warfarin? Department of Anesthesiology Rush University Medical Center Rush Medical College Chicago, IL Asokumar.
AntiThrombotic Therapy in the Cath Lab: Preliminary Results from the NICE Trials Cindy L. Grines, M.D. William Beaumont Hospital Royal Oak, Michigan Cindy.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
IN THE NAME OF GOD Dr.H-Kayalha Anesthesiologist.
Antithrombotic Therapy in Atrial Fibrillation Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis,
Anticoagulants and Neuraxial and Peripheral Nerve Blocks Gholamreza moradi, Cardiac Anesthesiologist, Kermanshah University of Medical Sciences.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Coagulation and anti-coagulants March Normal physiology Patophysiology Diagnostic tests Anticoagulants Anticoagulants and anesthesia.
Dr. Hadab A. Mohamed. BACKGROUND Temporary interruption Thrombotic risk Continuation Bleeding risk A great challenge, especially in the emergency setting.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
The management of anti-thrombotics in patients undergoing GI endoscopy
Regional anesthesia on anticoagulants
Anticoagulation after peripheral Vascular Intervention
Gramaglia L., Renghi A., Cassatella R., Martelli M., Brustia P.
Management of ST-Elevation Myocardial Infarction
Antithrombotic Therapy in Peripheral Artery Disease
When is it safe to do regional anaesthesia ?
Ischaemic Heart Disease Acute Coronary Syndrome
The normal haemostasis process involves three stages: 1
Tenecteplase (TNK-t-PA)‏
Thromboprophylaxis during labour and delivery
Chapter 28 Management of Patients With Coronary Vascular Disorders
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
Section F: Clinical guidelines
Presentation transcript:

Regional Anaesthesia and Thromboprophylaxis Dr Kate Fogg Royal Brompton Hospital

Regional Anaesthesia Regional AnaesthesiaEpidural/spinalRisks/benefits Thromboprophylaxis Thromboprophylaxis s/c heparin (unfractionated/LMWH) anti-Xa or direct thrombin inhibitors antiplatelet agents warfarin systemic heparinisation Can you put the two together or should you stop one in order to perform the other?

Regional blocks Drug administered directly to the spinal cord to locally block afferent and efferent nerve input. Drug administered directly to the spinal cord to locally block afferent and efferent nerve input. Usually for major thoracic, abdominal and lower limb surgery Usually for major thoracic, abdominal and lower limb surgery Local anaesthetic +/- opiates Local anaesthetic +/- opiates

Spinal Dural puncture Dural puncture Single shot usually Single shot usually 24-26G needle, pencil point 24-26G needle, pencil point Less traumatic Less traumatic Catheter rarely Catheter rarely

Epidural Larger needle – 16 G Larger needle – 16 G Loss of resistance technique Loss of resistance technique Epidural vessels Epidural vessels Usually a catheter technique Usually a catheter technique Trauma may be on insertion or removal of catheter Trauma may be on insertion or removal of catheter

Benefits Improved analgesia, greater mobility, fewer opiate side-effects Improved analgesia, greater mobility, fewer opiate side-effects Decrease stress response Decrease stress response adverse cardiac, pulmonary and immune outcomes hypercoagulable state Decrease troponin release in cardiac patients Decrease troponin release in cardiac patients ? Does this translate into clinical benefit ? Does this translate into clinical benefit

Most impressive in high-risk patients undergoing major surgery Most impressive in high-risk patients undergoing major surgery Decrease blood loss and transfusion requirement Decrease blood loss and transfusion requirement Decrease thromboembolic complications Decrease thromboembolic complications Decrease pneumonia and resp depression Decrease pneumonia and resp depression Decrease MI and ARF Decrease MI and ARF Decrease mortality Decrease mortality

Risks Failure Failure Dural Tap Dural Tap Catheter migration subdurally Catheter migration subdurally Nerve damage Nerve damage Epidural abscess Epidural abscess Epidural Haematoma Epidural Haematoma

Haematoma Rare but potentially catastrophic Rare but potentially catastrophic Tryba (1993) – 1:150,000 epidural anaesthetics, 1:220,000 spinals (review 1.5 million patients) Risk probably higher if on drugs altering coagulation Tryba (1993) – 1:150,000 epidural anaesthetics, 1:220,000 spinals (review 1.5 million patients) Risk probably higher if on drugs altering coagulation Vandermeulen (1994) review for case reports of haematoma Vandermeulen (1994) review for case reports of haematoma 75% associated with epidural, 25% spinal 75% associated with epidural, 25% spinal 87% coagulation abnormalities/technical difficulties 87% coagulation abnormalities/technical difficulties Coag abnormalities include alcohol abuse, CRF, thrombocytopaenia as well as drugs Coag abnormalities include alcohol abuse, CRF, thrombocytopaenia as well as drugs

Symptoms Sharp back pain Sharp back pain New motor/sensory loss New motor/sensory loss Urinary retention Urinary retention Variable and may be confused with effect of LA Variable and may be confused with effect of LA Paraplegia Paraplegia Need surgery within 8 hrs to get good or partial recovery. Need surgery within 8 hrs to get good or partial recovery.

Putting the two together? 1993 LMWH in USA b.d unlike in Europe o.d –sudden increase in reports of haematoma LMWH in USA b.d unlike in Europe o.d –sudden increase in reports of haematoma. American Society of Regional anaesthesia and Pain Medicine – Consensus Statement,2002 American Society of Regional anaesthesia and Pain Medicine – Consensus Statement,2002 German Society of Anaesthesia and Intensive Care Medicine 2004 German Society of Anaesthesia and Intensive Care Medicine 2004

Unfractionated heparin Vascular or cardiac cases Vascular or cardiac cases Avoid if other coagulopathy Avoid if other coagulopathy Heparin delayed for 1hour after needle placement Heparin delayed for 1hour after needle placement Catheter removal 2-4 hr after last heparin Catheter removal 2-4 hr after last heparin Post-op monitoring for at least 48 hrs Post-op monitoring for at least 48 hrs

Cardiac Does the benefit outweigh the risk? Does the benefit outweigh the risk? Can show less troponin release Can show less troponin release Consistent decrease in ventilator time Consistent decrease in ventilator time Better analgesia on day 1 Better analgesia on day 1 ?fewer pulmonary complications ?fewer pulmonary complications No consistent improvement in arrythmia/cardiac/renal/neurologic outcome No consistent improvement in arrythmia/cardiac/renal/neurologic outcome No effect on mortality No effect on mortality

Recent case reports of haematomas Recent case reports of haematomas Can achieve other benefits with beta blockers/multimodal analgesic techniques Can achieve other benefits with beta blockers/multimodal analgesic techniques ?only in high risk COPD patients or those elderly at high risk of confusion ?only in high risk COPD patients or those elderly at high risk of confusion

LMWH Dose dependent antithrombotic effect by anti-Xa inhibition Dose dependent antithrombotic effect by anti-Xa inhibition Anti-Xa level not predictive of bleeding Anti-Xa level not predictive of bleeding Beware antiplatelet or oral anticoagulant Beware antiplatelet or oral anticoagulant Needle placement hours after last dose LMWH Needle placement hours after last dose LMWH Higher dose….wait 24hrs Higher dose….wait 24hrs

Post-op: Post-op: Catheter technique safe Catheter technique safe B.D dosing; remove catheter beforehand. Wait 2hrs after catheter removal before first dose B.D dosing; remove catheter beforehand. Wait 2hrs after catheter removal before first dose O.D. can have indwelling catheter. Remove minimum of hours after last dose. Subsequent dose minimum 2hrs later O.D. can have indwelling catheter. Remove minimum of hours after last dose. Subsequent dose minimum 2hrs later

Oral anticoagulants Stop 4-5 days before Stop 4-5 days before PT/INR within normal limits PT/INR within normal limits If on low dose post-op need to monitor INR daily If on low dose post-op need to monitor INR daily Catheter removal when INR<1.5 Catheter removal when INR<1.5

Antiplatelet medications Include: aspirin, NSAIDs, thienopyridine derivatives (ticlodipine/clopidogrel), GP IIb/IIIa antagonists (abciximab/tirofiban) Include: aspirin, NSAIDs, thienopyridine derivatives (ticlodipine/clopidogrel), GP IIb/IIIa antagonists (abciximab/tirofiban) GPIIb/IIIa in acute coronary syndrome….unlikely to be heading for surgery where epidural needed GPIIb/IIIa in acute coronary syndrome….unlikely to be heading for surgery where epidural needed No wholly accepted test to guide antiplatelet therapy No wholly accepted test to guide antiplatelet therapy CLASP study in obstetric patients – aspirin alone does not increase risk CLASP study in obstetric patients – aspirin alone does not increase risk NSAID alone no increased risk NSAID alone no increased risk

Actual risk of haematoma with clopidogrel etc unknown. Actual risk of haematoma with clopidogrel etc unknown. Based on half-lives etc… Based on half-lives etc… Stop ticlodipine 14 days, clopidogrel 7 days Stop ticlodipine 14 days, clopidogrel 7 days GPIIb/IIIa contraindicated with 4 weeks GPIIb/IIIa contraindicated with 4 weeks Beware concurrent medications Beware concurrent medications

Little evidence increased surgical bleeding in non-cardiac studies Little evidence increased surgical bleeding in non-cardiac studies ? Stop only to make epidural safer (continue aspirin) ? Stop only to make epidural safer (continue aspirin) Usually on aspirin + clopidogrel because of intracoronary stent Usually on aspirin + clopidogrel because of intracoronary stent

Drug eluting stents Stop intimal hyperplasia which leads to early occlusion Stop intimal hyperplasia which leads to early occlusion Delay epithelialisation – hence need long term antiplatelet Rx Delay epithelialisation – hence need long term antiplatelet Rx Stopping antiplatelet Rx before surgery may increase risk of infarct (combine hypercoagulable state+ poorly endothelialised stent) Stopping antiplatelet Rx before surgery may increase risk of infarct (combine hypercoagulable state+ poorly endothelialised stent) Weigh benefit of epidural (and less surgical bleeding) v ischaemia/infarct Weigh benefit of epidural (and less surgical bleeding) v ischaemia/infarct ? Combine the two ? After platelet function ? Combine the two ? After platelet function

? Platelet function monitoring Spectrum of response to Rx Spectrum of response to Rx Can we identify which patients are higher risk? Can we identify which patients are higher risk? Bleeding time Bleeding time Optical light transmission aggregometry Optical light transmission aggregometry Platelet function analyser Platelet function analyser Modified TEG (Agarwal; Anaesthesiology 2006) Modified TEG (Agarwal; Anaesthesiology 2006)

Anti Xa fondaparinux Synthetic pentasaccharide, pure anti Xa Synthetic pentasaccharide, pure anti Xa 15hr half life 15hr half life Less venous thromboembolic events than with LMWH in orthopaedic patients Less venous thromboembolic events than with LMWH in orthopaedic patients Increased bleeding Increased bleeding Administered post-op (6hrs) Administered post-op (6hrs) No studies with indwelling epidural catheters No studies with indwelling epidural catheters Haematoma risk unclear Haematoma risk unclear

Thrombin inhibitors Recombinant hirudin dreivatives. Recombinant hirudin dreivatives. Inhibit free and clot bound thrombin Inhibit free and clot bound thrombin Argatobatran (L arginine derivative) similar action Argatobatran (L arginine derivative) similar action No case reports spinal haematoma No case reports spinal haematoma Reports of spontaneous intracerebral bleed Reports of spontaneous intracerebral bleed No risk assessment statement given! No risk assessment statement given!

For each individual patient a clear drug history is needed, an assessment of medical and surgical risk for their procedure, and an assessment of the additional benefit of a regional anaesthetic technique versus the risk of an epidural haematoma. In every patient undergoing a regional technique, rigorous post-op neurological monitoring is essential.

Questions?